<VariationArchive RecordType="classified" VariationID="96542" VariationName="NM_004320.6(ATP2A1):c.2595del (p.Asn866fs)" VariationType="Deletion" Accession="VCV000096542" Version="9" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-08-06" DateCreated="2015-06-29" MostRecentSubmission="2019-05-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="102436" VariationID="96542">
      <GeneList>
        <Gene Symbol="ATP2A1" FullName="ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" GeneID="487" HGNC_ID="HGNC:811" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="28878488" stop="28904466" display_start="28878488" display_stop="28904466" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="28889808" stop="28915829" display_start="28889808" display_stop="28915829" Strand="+" />
          </Location>
          <OMIM>108730</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004320.6(ATP2A1):c.2595del (p.Asn866fs)</Name>
      <CanonicalSPDI>NC_000016.10:28902649:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="28902650" stop="28902650" display_start="28902650" display_stop="28902650" variantLength="1" positionVCF="28902649" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="28913971" stop="28913971" display_start="28913971" display_stop="28913971" variantLength="1" positionVCF="28913970" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>N741fs</ProteinChange>
      <ProteinChange>N866fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.28902650del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.28902650del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.28913971del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.28913971del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023327.1" sequenceAccession="NG_023327" sequenceVersion="1" change="g.29163del">
            <Expression>NG_023327.1:g.29163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286075.2" sequenceAccession="NM_001286075" sequenceVersion="2" change="c.2220del">
            <Expression>NM_001286075.2:c.2220del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001273004.1" sequenceAccession="NP_001273004" sequenceVersion="1" change="p.Asn741fs">
            <Expression>NP_001273004.1:p.Asn741fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004320.6" sequenceAccession="NM_004320" sequenceVersion="6" change="c.2595del" MANESelect="true">
            <Expression>NM_004320.6:c.2595del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004311.1" sequenceAccession="NP_004311" sequenceVersion="1" change="p.Asn866fs">
            <Expression>NP_004311.1:p.Asn866fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173201.5" sequenceAccession="NM_173201" sequenceVersion="5" change="c.2595del">
            <Expression>NM_173201.5:c.2595del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_775293.1" sequenceAccession="NP_775293" sequenceVersion="1" change="p.Asn866fs">
            <Expression>NP_775293.1:p.Asn866fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA224215" DB="ClinGen" />
        <XRef Type="rs" ID="398124554" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004320.6(ATP2A1):c.2595del (p.Asn866fs) AND not provided" Accession="RCV000082697" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2015-08-07" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004320.6(ATP2A1):c.2595del (p.Asn866fs) AND Brody myopathy" Accession="RCV000326788" Version="5">
        <ClassifiedConditionList TraitSetID="5879">
          <ClassifiedCondition DB="MedGen" ID="C1832918">Brody myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-03" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-05-03" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-06-29" MostRecentSubmission="2019-05-24">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ATP2A1</URL>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2016-12-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5879" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="538" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Brody myopathy</ElementValue>
                <XRef ID="Brody+Myopathy/968" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010977" DB="MONDO" />
                <XRef ID="703530005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRODY DISEASE</ElementValue>
                <XRef Type="MIM" ID="601003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="108730.0009" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9158" />
                <XRef ID="9158" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53347" DB="Orphanet" />
              <XRef ID="C1832918" DB="MedGen" />
              <XRef ID="MONDO:0010977" DB="MONDO" />
              <XRef Type="MIM" ID="601003" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1102370" SubmissionDate="2019-01-29" DateLastUpdated="2015-06-29" DateCreated="2015-06-29">
        <ClinVarSubmissionID localKey="GDX:474869|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000567263" DateUpdated="2015-06-29" DateCreated="2015-06-29" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-08-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2595delC deletion in the ATP2A1 gene has not been reported previously as a pathogenic variant nor as a benign polymorphism, to our knowledge. The c.2595delC deletion causes a frameshiftstarting with codon Asparagine 866, changes this amino acid to a Threonine residue, and creates apremature Stop codon at position 5 of the new reading frame, denoted p.Asn866ThrfsX5. This variant ispredicted to cause loss of normal protein function either through protein truncation or nonsense-mediatedmRNA decay. The c.2595delC deletion was not observed in approximately 6,500 individuals of Europeanand African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a commonbenign variant in these populations. We interpret c.2595delC as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_173201.3:c.2595delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="709927" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="840176" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000396406" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The ATP2A1 c.2595delC (Asn866ThrfsTer5) variant results in a frameshift and is predicted to result in premature termination of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is not found in the 1000 Genomes Project, the Exome Sequencing Project, the Exome Aggregation Consortium, or the Genome Aggregation Database. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for Brody myopathy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="T" referenceAllele="TC" start="28913970" stop="28913971" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_173201.3:c.2595delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601003" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="196852" SubmissionDate="2018-09-19" DateLastUpdated="2015-06-29" DateCreated="2014-01-17">
        <ClinVarSubmissionID localKey="8434_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000114741" DateUpdated="2015-06-29" DateCreated="2014-01-17" Type="SCV" Version="8" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-04-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATP2A1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="-" referenceAllele="C" start="28913971" stop="28913971" variantLength="1" />
            <GeneLocation>NM_173201.3:Ex18</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ATP2A1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="196852" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="709927" TraitType="Disease" MappingType="XRef" MappingValue="601003" MappingRef="OMIM">
        <MedGen CUI="C1832918" Name="Brody myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1102370" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

